Literature DB >> 17611902

Control by reproduction-related hormones of resistin expression and plasma concentration.

S Caja1, M Puerta.   

Abstract

Although not simultaneously, resistin expression in white adipose tissue (WAT) and resistin plasma concentration have been shown to increase in pregnant rats. To clarify the involvement of sex hormones in such increases, we administered for 3-5 days progesterone, estradiol, or human chorionic gonadotropin (hCG) to female rats in dioestrus II. Progesterone increased resistin expression retroperitoneal WAT but lacked effect in parametrial or subcutaneous depots. It also increased resistin plasma concentration. Estradiol decreased resistin expression in both parametrial and inguinal WAT but was without effect on retroperitoneal depots. It did not alter plasma resistin. Human hCG increased resistin expression in all the visceral depots examined - parametrial, inguinal and retroperitoneal - but did not change plasma resistin. These results show that hormonal influences in resistin expression are depot-dependent and can run separately from changes in its plasma concentration. Besides, the locally restricted effect of progesterone in resistin expression compared with that of hCG suggests it is not the only hormone enhancing resistin expression in early pregnancy. However, it could enhance resistin release in late pregnancy. Estradiol could be involved in the decrease of resistin expression in late pregnancy. Finally, since hCG acts through LH receptors, our results suggest that they are present in WAT and that they control resistin expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17611902     DOI: 10.1055/s-2007-982515

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  6 in total

1.  Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular Metabolism.

Authors:  Xinping Chen; Megha Talati; Joshua P Fessel; Anna R Hemnes; Santhi Gladson; Jaketa French; Sheila Shay; Aaron Trammell; John A Phillips; Rizwan Hamid; Joy D Cogan; Elliott P Dawson; Kristie E Womble; Lora K Hedges; Elizabeth G Martinez; Lisa A Wheeler; James E Loyd; Susan J Majka; James West; Eric D Austin
Journal:  Circulation       Date:  2015-10-20       Impact factor: 29.690

2.  Interaction between bone morphogenetic protein receptor type 2 and estrogenic compounds in pulmonary arterial hypertension.

Authors:  Joshua P Fessel; Xinping Chen; Andrea Frump; Santhi Gladson; Tom Blackwell; Christie Kang; Jennifer Johnson; James E Loyd; Anna Hemnes; Eric Austin; James West
Journal:  Pulm Circ       Date:  2013-12-02       Impact factor: 3.017

3.  Cardiovascular risk in Egyptian healthy consumers of different types of combined oral contraceptives pills: A comparative study.

Authors:  Sahar M El-Haggar; Tarek M Mostafa
Journal:  Endocrine       Date:  2014-12-25       Impact factor: 3.633

4.  Total and regional body adiposity increases during menopause-evidence from a follow-up study.

Authors:  Hanna-Kaarina Juppi; Sarianna Sipilä; Vasco Fachada; Matti Hyvärinen; Neil Cronin; Pauliina Aukee; Jari E Karppinen; Harri Selänne; Urho M Kujala; Vuokko Kovanen; Sira Karvinen; Eija K Laakkonen
Journal:  Aging Cell       Date:  2022-05-04       Impact factor: 11.005

5.  Hypothalamic effects of progesterone on regulation of the pulsatile and surge release of luteinising hormone in female rats.

Authors:  Wen He; Xiaofeng Li; Daniel Adekunbi; Yali Liu; Hui Long; Li Wang; Qifeng Lyu; Yanping Kuang; Kevin T O'Byrne
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

Review 6.  Gender, sex hormones and pulmonary hypertension.

Authors:  Eric D Austin; Tim Lahm; James West; Stevan P Tofovic; Anne Katrine Johansen; Margaret R Maclean; Abdallah Alzoubi; Masahiko Oka
Journal:  Pulm Circ       Date:  2013-04       Impact factor: 3.017

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.